Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)
Year: 2020
Type: article
Abstract: Maraviroc (MVC) is a candidate for human immunodeficiency virus (HIV) pre-exposure prophylaxis.
DOI: 10.17615/m2r7-rg29
Authors: McGowan, Ian, Frank, Ian, Eshleman, Susan H, Ho, Ken, Salata, Robert A, Santana, Jorge, Hendrix, Craig W, Rivet Amico,, Liu, Albert, Chen, Ying Q, Chege, Wairimu, Rinehart, Alex R, Richardson, Paul, Klingman, Karin L, Andrade, Adriana, Landovitz, Raphael J, Marzinke, Mark A, Wilkin, Timothy J, Cottle, Leslie M, Mayer, Kenneth H, Stekler, Joanne D, Marcus, Cheryl, Young, Alicia M, Farley, Jason E, Magnus, Manya, Gulick, Roy M, Andrew, Philip, Rooney, James F, McCauley, Marybeth
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Bristol-Myers Squibb, GlaxoSmithKline, Gilead Sciences, University of Pennsylvania, George Washington University, University of Washington, Johns Hopkins University, University of Pittsburgh, ViiV Healthcare, FHI 360, National Institutes of Health, University of California, Los Angeles, Weill Cornell Medical College, University of North Carolina at Chapel Hill, University of California, San Francisco, National Institute of Allergy and Infectious Diseases, National Center for Research Resources
Awards: G1479152345, G1507718124, G174905615, G1852790566, G2507544392, University of Pittsburgh Clinical and Translational Science Institute, G3788978964, University of Pittsburgh Clinical and Translational Science Institute, G5768112423, G674907753, G7348756, G749807406, G8852914737, HIV Prevention Trials Network Leadership and Operations Center, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Penn Center for AIDS Research, The University of North Carolina Center for AIDS Research, LC: HIV PREVENTION TRIALS NETWORK, SDMC: HIV Prevention Trials Network
OpenAlex ID: W4300902473